A monoclonal antibody was used to characterize a 135-kDa surface-located membrane protein (Lmp1) generally present in Mycoplasma hominis strains. The monoclonal antibody, 552, was applied to identify the corresponding gene in an expression library of M. hominis PG21 DNA. The M. hominis PG21 lmp1 gene was sequenced, and its gene product was characterized with the goal of elucidating the structure and function of Lmp1. A total of 7,196 bp in the lmp1 region was sequenced. An open reading frame of 4,032 bp, encoding a protein of 1,344 amino acids with a calculated molecular weight of 147,000, was identified. Analysis of the deduced amino acid sequence predicted a hydrophilic protein with a basic pI (10.0). The N-terminal 24 amino acids were a typical leader sequence. Downstream from the first 726 nucleotides, six similar direct repeats of 471 nucleotides were found. In repeat 7, a single-base substitution, C3A, gave rise to the stop codon of lmp1. Thus, the C-terminal 945 amino acids were encoded by the 471-bp direct repeats. As evidenced by Southern blot analysis, the gene encoding the 135-kDa antigen is part of a multigene family. One of the genes, lmp2, was situated directly downstream from lmp1 where the direct repeats continued.
Mycoplasmas are the smallest self-replicating microorganisms that can be cultivated in cell-free media. These prokaryotes are phylogenetically related to gram-positive bacteria, and their genome is the smallest recorded in living cells (39) . Mycoplasma hominis is an opportunistic pathogen capable of invading the upper genitourinary tract and is of etiologic significance in pyelonephritis, salpingitis, postpartum fever, and infection of amniotic fluid. Extragenital infections with M. hominis are recognized with increasing frequency (12) .
Like all mycoplasmas, M. hominis lacks the typical bacterial cell wall and is thus separated from the surroundings only by a plasma membrane. It interacts with host cells by surface colonization through structures exposed on the single limiting membrane. Surface-exposed membrane antigens are also important targets for immune responses (31, 50) . Therefore, the identification and characterization of common and variable proteins exposed on the surface of M. hominis will contribute not only to improved methods of serologic detection but also to a better understanding of the pathogenesis of disease.
M. hominis is one of the most heterogeneous mycoplasma species. It shows a marked phenotypic and genotypic diversity (2, 4, 15) . The heterogeneity is seen mainly in surface antigens, as demonstrated by serological analysis, whereas cytoplasmic antigens are conserved (10; for a review, see reference 14) .
We have previously reported on nine monoclonal antibodies (MAbs) reacting with six surface-exposed polypeptides of M. hominis PG21 (type strain) (34) . The binding patterns to 26 M. hominis strains revealed that six of the MAbs reacted with polypeptides of different sizes present in from 6 to 25 M. hominis strains and that some MAbs were capable of binding epitopes on several polypeptides. The remaining three MAbs identified antigens with less pronounced size variation found in all 26 strains. One of these, MAb 552 (isotype immunoglobulin G2b [IgG2b]), reacted with a ladder of polypeptides ranging in size from 153 to 93 kDa in four strains, including M. hominis PG21, as opposed to the remaining 22 strains, in which it reacted with a single band of 93 kDa.
As a first step to analyze the genetic background for antigenic variation identified by the MAbs, Hauge et al. (26) cloned Sau3AI restriction fragments of DNA from M. hominis PG21 into the expression vector system pEX (44) . Cloned fragments expressing epitopes recognized by the MAbs were used as probes in Southern blots to analyze for restriction fragment length polymorphism (RFLP) in the 26 M. hominis strains. One clone identified by MAb 552 (pMhX1-28) showed pronounced RFLP with respect to both fragment size and the number of fragments recognized by the probe (16) , despite the fact that the epitope for MAb 552 was conserved in all 26 strains and was located on polypeptides of quite uniform size. Even though the insert of pMhX1-28 did not contain any EcoRI sites, it hybridized to two EcoRI fragments of 6 and 11 kb in M. hominis PG21. This finding indicated the existence of a duplicated part of the gene coding for the MAb 552-reacting antigen (16) .
The apparent discrepancy between the uniform binding pattern in immunoblots of MAb 552 to the 26 M. hominis strains and the complicated RFLP found by using pMhX1-28 on the same strains together with the involvement of repetitious DNA elements made us study the gene in detail. Here we report the nucleotide sequence of the gene encoding the 135-kDa surface protein harboring the epitope of MAb 552. We demonstrate a very complicated gene structure involving intragenic as well as extragenic repetitious elements.
MATERIALS AND METHODS
Mycoplasma strains and cultivation. The mycoplasma strains were all obtained from the International Mycoplasma Reference Centre, Aarhus, Denmark. M. hominis strains, Mycoplasma orale CH19299, Mycoplasma arthritidis PG6, Mycoplasma buccale CH20247, and Mycoplasma salivarium PG20 were grown in BEA medium, Mycoplasma fermentans PG18 and Mycoplasma pneumoniae FH were grown in BEG medium, and Mycoplasma genitalium G37 was grown in SP4 medium (23) . Each mycoplasma strain was filter cloned according to the recom-mendation from the Subcommittee of the Taxonomy of Mollicutes (28) and subsequently freeze dried. Mycoplasma stock culture was propagated from the same freeze-dried culture and kept at Ϫ70ЊC until used in the different assays.
Antigen preparation. Mycoplasmas were harvested by centrifugation at 20,000 ϫ g for 30 min at 4ЊC and washed twice in ice cold phosphate-buffered saline, pH 7.2 (PBS). The pellet was resuspended in PBS for immunization experiments or in sodium dodecyl sulfate (SDS) sample buffer (125 mM Tris [pH 6.8], 2.4% [wt/vol] SDS, 5% ␤-mercaptoethanol, 10% [wt/vol] glycerol) at 60ЊC for enzymelinked immunosorbent assay (ELISA) or SDS-polyacrylamide gel electrophoresis (PAGE). The samples were stored at Ϫ20ЊC.
Production and propagation of MAbs. MAbs were established essentially as described by Köhler and Milstein (30) . Three-month-old BALB/c mice were immunized by subcutaneous injections five times at 7-day intervals with 100 g of M. hominis PG21 protein (35) . The protein was emulsified in Freund's incomplete adjuvant (Difco Laboratories, Detroit, Mich.). At days 90 and 91, injections of 200 g of protein suspended in PBS were given intraperitoneally, and at day 93, the spleen cells were harvested (42) . Spleen cells (5 ϫ 10 8 ) were fused with 2.5 ϫ 10 8 NS-1 azoguanine-resistant cells (American Type Culture Collection, Rockville, Md.) in the presence of 50% polyethylene glycol (Sigma Chemical Co., St. Louis, Mo.). For fusion and subcloning done with limiting-dilution conditions, peritoneal macrophages from 6-week old BALB/c mice were used as feeder cells. The medium for cultivation of hybridoma cells was RPMI 1640 containing 15% heat-inactivated fetal calf serum (GIBCO Laboratories, Grand Island, N.Y.), 15% NS-1 conditioned medium, 1 mM pyruvate, 0.1 mM hypoxanthine, 0.4 M aminopterin, 16 M thymidine, and 50,000 IU of penicillin per liter. For detection of segregated antibodies from hybridoma cells, an indirect ELISA was used (6) . Cells from positive wells were cloned by limiting dilution. Cloned hybridoma cells were further propagated in the medium used for production of MAbs except that the NS-1 conditioned medium and aminopterin were excluded. SDS-PAGE and immunoblotting. Mycoplasma antigens in SDS sample buffer were separated by SDS-PAGE under reducing conditions, and nitrocellulose filter blots were prepared as described by Andersen et al. (2) . Strips of the filter blots were incubated with hybridoma culture fluids diluted in antibody buffer 1:10. Goat anti-mouse, horseradish peroxidase-conjugated IgG secondary antibodies were used in a dilution of 1:3,000. Chloronaphthol was used as the chromogen. The apparent molecular weight of immunologically stained components was determined by comparison with molecular weight standards including myosin (200,000), ␤-galactosidase (116,300), phosphorylase b (97,400), bovine serum albumin (66,300), glutamic dehydrogenase (55,400), lactate dehydrogenase (36,500), carbonic anhydrase (31,000), trypsin inhibitor (21,500), lysozyme (14, 400) , and aprotinin (6,000) (Novex, San Diego, Calif.).
Triton X-114 phase partitioning of M. hominis antigens. M. hominis PG21 was grown in BEA medium to mid-log phase, harvested, and washed in PBS. The cells were lysed on ice for 30 min in a buffer containing 1% Triton X-114, 10 mM Tris-HCl (pH 7.4), and 150 mM NaCl (protein concentration was adjusted to 1 mg/ml). The lysate was centrifuged at 20,000 ϫ g for 30 min at 4ЊC to remove insoluble components. The supernatant was used for Triton X-114 phase partitioning as described by Bordier (9) . The distribution of proteins in the insoluble, Triton X-114, and aqueous fractions was analyzed by immunoblotting with MAb 552.
Adhesion inhibition assay. M. hominis PG21 cells (8 ϫ 10 8 ) were incubated with MAb 552 diluted 1:6 for 1 h at 37ЊC. The mixture was transferred to semiconfluent HeLa cell monolayers on coverslips and incubated for 1 h at 37ЊC. Adhesion of M. hominis to HeLa cells was observed by Hoechst staining (Sigma). Exposures to PBS and MAb 30.3.1 (16) served as negative controls, whereas exposure to rabbit hyperimmune serum (2) diluted 1:1,600 against PG21 served as a positive control.
Immunoelectron microscopy. One drop of mid-log-phase M. hominis PG21 cells (with or without prior fixation in 0.25% glutaraldehyde for 5 min at room temperature) was placed on top of a Parlodion-carbon-coated, glow-discharged copper grid (29) for 1 min. The grids were blocked in PBS containing 0.5% ovalbumin for 15 min, washed in PBS, and incubated for 30 min at 37ЊC with MAb 552 diluted 1:5. The grids were then washed three times in PBS containing 1% cold water fish gelatin and incubated with secondary antibodies (goat antimouse Ig colloidal gold [10 nm] conjugated; Dakopatts) for 30 min at 37ЊC. The grids were washed twice in PBS with 1% gelatin for 30 min at 37ЊC and twice in PBS. Finally, the grids were stained with 0.5% phosphotungstic acid (pH 7.0) and blotted dry. The grids were examined in a JOEL 100B electron microscope.
Growth inhibition (GI) assay. The potential growth-inhibiting action of MAb 552 was investigated on solid medium and in broth culture. The growth inhibition assay on agar was performed as described by Black (8) . Ten microliters of M. hominis PG21 was allowed to run down the surface of the agar plate. After drying, the antibodies were applied in the middle of the streak in a 4-mmdiameter well. Hybridoma medium served as a negative control. The inoculated plates were incubated in 5% CO 2 for 4 or 5 days. The plates were examined under a stereomicroscope (Leitz), and the zones of inhibition were measured in millimeters.
The GI test in broth medium without complement was performed essentially as described by Brunner et al. (11) . Mycoplasmas (0.5 ϫ 10 7 CFU/ml) were incubated in 2.5 ml of broth culture medium, and various concentrations of MAb 552 or 30.3.1 in hybridoma medium were added. The cultures were left at 37ЊC for 6 h. To determine the number of CFU, six serial 10-fold dilutions in BEA medium were performed in duplicate. Aliquots of 10 l were plated on BE agar. After 4 to 5 days of incubation at 37ЊC in 5% CO 2 , the colonies were counted. The survival fraction was determined by comparison of controls with cells exposed to MAb 552 (11) .
Metabolic inhibition (MI) assay. The complement-independent reduction in metabolism of arginine by MAbs resulting in an alkaline shift in the pH of the medium was analyzed in microtiter plates as described by Feldmann et al. (20) . The extinctions were read in an ImmunoReader NJ2000 (Teknunc, Roskilde, Denmark) by dual mode at 540 and 620 nm.
DNA fluorometric assay. In the DNA fluorometric assay, the cell number is monitored by the DNA content of the broth culture. The cultivation of M. hominis PG21 with MAb 552 or 30.3.1 was as in the MI assay except that the incubation volume was 1 ml. At fixed intervals, three cultures were withdrawn for measurement of the DNA content. Mycoplasma DNA content was determined using the fluorescent dye Hoechst 33258 by the test of Rao and Otto (38) , with modifications as follows. A 0.5-ml volume of M. hominis broth culture was centrifuged at 20,000 ϫ g for 10 min at 4ЊC. The pellet was dissolved in 900 l of H 2 O, vortexed, and stored at Ϫ70ЊC. After thawing, 100 l of proteinase K (Boehringer) was added to a concentration of 1 mg/ml and left for 30 min at 37ЊC. One ml of Hoechst 33258 (20 mg/ml) in TNE buffer (10 mM Tris-HCl, 1 mM EDTA, 2 M EDTA [pH 7.4]) was added, and fluorescence was measured on a TKO 100 minifluorometer (Hoefer Scientific Instruments, San Francisco, Calif.). Calf thymus DNA (Hoefer Scientific Instruments) was used as standard. The assay generates a linear correlation for DNA fluorescence versus cell number (37) .
Agglutination assay. Mid-log-phase cultures of M. hominis PG21 in BEA medium were incubated overnight at 37ЊC in the presence or absence of MAbs added to the medium. Samples were stained with Hoechst 33258 (0.05 g/ml) and observed under coverslips, using a Leitz Orthoplan fluorescence microscope (E. Leitz GmbH, Wetzlar, Germany).
DNA manipulation and sequencing. M. hominis DNA for agarose gel electrophoresis and cloning was isolated as described earlier (32) . Plasmid DNA was prepared by the alkaline lysis method described by Sambrook et al. (41) . Restriction enzyme digestion and agarose gel electrophoresis were done as described by Sambrook et al. (41) . DNA transfer to Hybond-N membrane (Amersham International plc, Amersham, United Kingdom), Southern hybridization, and colony blot hybridization were carried out as described by Sambrook et al. (41) . DNA fragments were labeled with [␣-32 P]dATP by nick translation using standard methods (41) . For recovery of restriction fragments from agarose gels, for cloning, or for nick translation, electrophoresis was performed through a 1.0% low-gelling-temperature agarose (SeaPlaque GTG agarose; FMC BioProducts, Rockland, Maine). Bands were visualized with ethidium bromide. Gel slices containing the appropriate restriction fragments were excised and melted at 62ЊC before purification by phenol-chloroform extraction and ethanol precipitation. DNA sequencing of denatured double-stranded DNA was done by the method of Hattori and Sakaki (25) with Sequenase version 2 (United States Biochemical Corporation, Cleveland, Ohio).
Cloning of M. hominis PG21 DNA for sequencing. E. coli XL1-blue (Stratagene, La Jolla, Calif.) was used as the host for the phagemid pBluescript (Stratagene) and their derivatives. The strains were cultivated in Luria-Bertani (LB) broth or Terrific broth (41) .
Cloning of M. hominis PG21 DNA into the expression vector system pEX. M. hominis PG21 DNA was partially digested with Sau3AI to an average fragment size of 2 kb. The expression vectors pEX1, pEX2, and pEX3 (44) were opened with BamHI and dephosphorylated with calf intestinal phosphatase (Boehringer GmbH, Mannheim, Germany) (41). The M. hominis PG21 DNA fragments were ligated to DNA from vectors pEX1, pEX2, and pEX3 with T4 ligase (2 U/g) for 16 h at 12ЊC (41) . The recombinant plasmids were transformed into competent Escherichia coli K-12 strain PL248 (5). Recombinants were cultivated on LB plates with 50 mg of kanamycin and 100 mg of ampicillin per liter. Transfer of colonies, growth of colonies on nitrocellulose, lysis of colonies with SDS, and electroelution of SDS were done by the methods of Stanley (43) . Immunodetection of recombinants expressing M. hominis PG21 antigens was performed with MAb 552 as for immunoblotting.
Cloning of M. hominis PG21 DNA into the cosmid vector pWE-15. Highmolecular-weight M. hominis DNA was partially digested with Sau3AI. The DNA was size fractionated by sucrose gradient centrifugation. Fragments of 30 to 45 kb were selected and cloned into the cosmid-vector pWE-15 (Stratagene) opened in the unique BamHI site as described by DiLella and Woo (19) . The DNA was packed in vitro with Gigapack (Stratagene) according to the manufacturer's recommendations and then transfected into E. coli AG1. The cells were plated on LB agar plates with ampicillin (100 g/ml) and grown overnight at 37ЊC. From 200 randomly selected colonies, plasmid DNA was recovered, denatured by 0.2 M NaOH, and placed on Hybond-N nylon membranes (Amersham). Recombinant pMhCos was detected with radioactively labeled probes (41) .
Sequence analysis. The sequence data were compiled and analyzed with the Genetics Computer Group sequence analysis software package, version 7. (13) . Northern blot hybridization of M. hominis RNA was performed as described by Sambrook et al. (41), using a 0.24-to 9.5-kb RNA ladder (Life Technologies Inc., Gaithersburg, Md.) as a molecular weight marker.
Nucleotide sequence accession number. The sequence data presented here will appear in the EMBL data library under accession number X81475.
RESULTS
Characterization of the mycoplasma component recognized by MAb 552. MAb 552 raised against the type strain M. hominis PG21 described earlier (16, 34) was investigated in details. In immunoblotting, MAb 552 reacted with a major constituent with an apparent molecular weight of 135,000 (Lmp1). Additional bands ranging in size from 130 to 93 kDa were also seen. Lmp1 was sensitive to proteinase K treatment, implicating its proteinaceous nature. MAb 552 was specific for M. hominis and showed by immunoblotting no cross-reactivity with seven different mycoplasma species recognized as occurring in humans (M. orale CH19299, M. arthritidis PG6, M. buccale CH20247, M. salivarium PG20, M. fermentans PG18, M. pneumoniae FH, and M. genitalium G37).
Triton X-114 partitioning (9) was performed on M. hominis PG21 proteins in order to assess the hydrophobicity/hydrophilicity characteristic of Lmp1. The proteins in the Triton X-114, aqueous, and insoluble fractions were analyzed by immunoblotting with MAb 552. The results are shown in Fig. 1 . The majority of the Lmp1 protein was found in the insoluble phase and was thus not extracted by the procedure. The extracted part of Lmp1 was found in equal amounts in the aqueous phase and in the Triton X-114 phase (Fig. 1) . The presence of Lmp1 in both phases indicates that the protein may be a hydrophilic peripheral membrane protein that is incompletely separated from an integral membrane protein during the Triton X-114 extraction (9) . The MAb 43.2-reactive antigen, which is a surface-exposed integral membrane protein, served as a control of the extraction procedure (34) .
Localization of the 135-kDa antigen at the surface of mycoplasmas. Lmp1 has previously been identified as a surfaceexposed protein by immunofluorescence staining of intact mycoplasma cells (34) . The cellular localization of the protein was further analyzed by immunoelectron microscopy. On glutaraldehyde-fixed M. hominis PG21 cells, the immunogold labeling was seen equally distributed over the surface of the cells (Fig.  2A) . On unfixed cells, the labeling was seen mostly at the periphery of the cells, indicating that the protein can move in the lipid bilayer of the membrane (Fig. 2B) . MAb 26.3 of the same isotype reacting with C. trachomatis L2 (MOMP) served as negative control and showed that no gold was bound to the cells (Fig. 2C) .
In vitro effects of MAb 552 on growth and metabolism. Compared with controls (Fig. 2D) , incubation of MAb 552 with suspensions of M. hominis PG21 resulted in production of large aggregates of M. hominis PG21 cells visualized by fluorescence microscopy after Hoechst 33258 staining (Fig. 2E) . In control experiments without antibodies or with MAb 30.3.1, no agglutination was observed.
When the GI test was performed on agar plates, no inhibition zone was obtained with MAb 552 compared with controls. A dense, even distribution of mycoplasma colonies was seen on the plates. Polyclonal antibodies against M. hominis PG21 served as positive control and displayed a significant growthinhibiting zone. Thus, on agar plates, MAb 552 did not inhibit growth of M. hominis PG21.
Since the agar GI test is a very specific but quite insensitive assay (17), MAb 552 was thus further investigated by a GI assay performed in broth medium as well as an MI test. In the GI assay performed in broth culture, growth of M. hominis PG21 was shown to reduce the CFU when MAb 552 was added to the medium (Fig. 3A) . At a MAb 552 concentration of 3 g/ml, we found a reduction in CFU of 89% compared with the number of CFU when no MAb was added to the growth medium. Additional increase in the MAb 552 concentration did not result in a further reduction in CFU. The reduction in CFU may in part be explained by the large aggregates produced when MAb 552 is added to cultures of M. hominis PG21. In a control experiment, MAb 30.3.1, which also reacted with a surface-localized polypeptide in M. hominis PG21 (34), was added to the medium. No GI was observed (Fig. 3A) . Figure 3B shows the results of the MI assay. Compared with controls, the MI assay showed a significant reduction of metabolic activity of M. hominis PG21 when MAb 552 was added to the culture medium. Addition of MAb 30.3.1 to the growth medium did not have any significant effect on the metabolism of arginine. Figure 3C demonstrates the effect of MAb 552 on the amount of cellular DNA. Cellular DNA content is an indirect measure of cell number. The number of cells in the culture containing MAb 552 compared with the control containing MAb 30.3.1 was reduced by 53% after 35 h, at which time the most substantial difference was seen. This result demonstrated a reduced cell multiplication.
MAb 552 did not confer any inhibition of adherence of M. hominis PG21 to HeLa cells in the adhesion inhibition assay.
Cloning and characterization of the gene encoding the 135-kDa polypeptide. MAb 552 was used to screen a gene library of M. hominis PG21 DNA cloned into the expression vectors pEX1, pEX2, and pEX3 (5). Several recombinant clones expressed the epitope recognized by MAb 552, and one of these was pMhX1-28. A restriction map of pMhX1-28 was constructed, and the plasmid or part of it was used in Southern hybridization experiments in order to make a restriction map of the region on the M. hominis chromosome. The region was found to contain multiple HindIII and EcoRV sites regularly spaced by 0.47 kb. To clone the region upstream of pMhX1-28, an overlapping clone, pBMhB616A, from an M. hominis PG21 BglII library made in pBluescript SKϩ was identified by using Figure 4 shows partial restriction digests of pBMhB616A made in order to map the insert and compare it with the chromosomal map as well as with pMhX1-28. From these results, it was possible to make a HindIII-EcoRV restriction map of pBMhB616A, and it was found to be identical to the chromosomal map (Fig. 5) . Examination of the pMhX1-28 map demonstrated that a part equivalent to a 0.47-kb fragment localized in the rep2-rep3 region on the chromosomal map was missing ( Fig. 5 ; hatched part of pMhX1-28). Since the 3.8-kb Sau3AI fragment found in pMhX1-28 could not be detected in Southern blots of Sau3AI-cleaved M. hominis PG21 DNA probed with pMhX1-28, it was concluded that the missing part of pMhX1-28 probably was the result of a deletion during the cloning procedure. It is, of course, also possible that the M. hominis PG21 DNA contained a minor subpopulation containing the 3.8-kb Sau3AI fragment. Precautions were, however, taken to prevent this, as the original M. hominis PG21 strain had been filter cloned prior to cultivation for DNA preparation. The region downstream of pBMhB616A was cloned as follows (Fig. 5) . Clone p188E5-2 containing a 1.5-kb EcoRV-BglII fragment was subcloned from a recombinant cosmid (pMhCos-188). This cosmid was identified by hybridization to our cosmid library to contain the 3Ј part of pBMhB616A. Clone pH10G6-3 was identified by hybridization from an M. hominis PG21 HindIII library in pBluescript KSϩ to contain the 3Ј part of p188E5-2. pBMhS38-1 and pBMhS14-2 were Sau3AI fragments subcloned from pMhX1-28.
The restriction map showed that the central part of the region contained multiple EcoRV and HindIII sites all separated by 0.47 kb, which made an unambiguous subcloning of overlapping restriction fragments impossible. Therefore, subclones for sequencing in this region were made by partially digesting pBMhS38-1 and pBMhS14-2 with HindIII. The DNA sequence in the diverging region (hatched on Fig. 5 ) was determined from comparison of clone pLMPE5-1 with pBMhS38-1. pLMPE5-1 contained a 1-kb EcoRV fragment subcloned from pMhCos-393, another clone derived from the cosmid library.
The sequencing strategy for determination of the nucleotide sequence is shown in Fig. 5 . The nucleotide sequence is shown in Fig. 6 . In spite of the nucleotide deletion in pMhX1-28, the reading frame was maintained, and the only tryptophan codon in the consensus gene was substituted with a serine codon in pMhX1- 28. Two major open reading frames in the sequenced region 
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were identified and designated Lmp1 (from bp 171 to 4202) and Lmp2 (from bp 4206 to 7091) ( Fig. 5 and 6 ). Upstream the start methionine of Lmp1 sequence motifs similar to those expected for transcriptional promoters were identified. Nineteen base pairs downstream the start of the putative gene, a perfect inverted repeat of 10 bp separated by 6 bp was observed. Downstream Lmp2, a putative termination structure in the form of an inverted repeat of 11 bp separated by 4 bp was seen (Fig. 6) . At 726 bp downstream of the start methionine of Lmp1 (at position 897), nine and a half direct repeats of 471 bp were positioned. The repeated elements stopped at position 5413 in the middle of the 10th repeat. A consensus repeat was identified and was present in five of the nine complete repeats (Fig.  5) . Four variant repeats were found. In variant A, a base substitution, A3G (nucleotide [nt] 1347), was identified, resulting in the generation of a Sau3AI site. Variant B contained both the A3G base resulting in generation of a Sau3AI site (nt 4644) and an additional base substitution, C3A (nt 4203), resulting in the generation of a stop codon. Variant C was characterized by the generation of a Sau3AI site as a result of a A3G base substitution at nt 1818, as well as a base substitution at nt 1616 resulting in the disappearance of an EcoRV site. Variant D had base substitution C3G at nt 1870, resulting in serine (S)-to-tryptophan (W) substitution. The nucleotide deviations from the consensus repeat are shown above the sequence in Fig. 6 .
Expression of the cloned gene product. E. coli pMhX1-28 contained a 5.2-kbp insert of the lmp gene that expressed the epitope recognized by immunoblotting with MAb 552. A 471-bp EcoRV fragment from pMhX1-28 containing the consensus repeat was cloned into the SmaI site of pEX3, expressed, and shown by immunoblotting to react with a single antigen of 135 kDa, using MAb 552 as the antibody (data not shown). In the pEX3 vector, a recombinant protein is expressed as a fusion protein consisting of the truncated cro-␤-galactosidase of 117 kDa and the cloned gene product. The plasmid expressing the cloned consensus repeat showed accordingly an increase in protein size of 18 kDa, which is as predicted from the coding capacity of the DNA sequence. The epitope for MAb 552 was thus localized in the repeated part of Transcription of the lmp gene in M. hominis. Northern blotting on M. hominis PG21 was carried out with a probe containing the nonrepetitious part of Lmp1 (pBMhAS-16) as well as pBMhS38-1 containing the repeated part (Fig. 5) . In either case, the probe hybridized to a fragment of 7.2 kb (Fig. 7) . This size is in agreement with the size of the transcript predicted from the nucleotide sequence of lmp1 and lmp2.
Analysis of Lmp1. The deduced amino acid sequence of lmp1 revealed a polypeptide of 1,344 residues. The N-terminal 25 amino acids constituted a typical hydrophobic leader sequence with a cleavage site for signal peptidase I determined by the method of von Heijne (48) (Fig. 6 ). Hydropathy analysis of the mature polypeptide showed a generally hydrophilic protein lacking a hydrophobic membrane anchor sequence. Lmp1 is thus probably attached to the outer cell surface by electrostatic interaction with other membrane components. The mature peptide has an isoelectric point of 9.97 and a deduced molecular mass of 147 kDa, which is in good agreement with the molecular mass estimated by SDS-PAGE (135 kDa). The gene contained a single tryptophan codon which in mycoplasmas is encoded by the universal stop codon UGA in addition to UGG (51) . There is only one cysteine present in the gene. Therefore, the flexibility of the polypeptide chain is not limited by disulfide bonds. The open reading frame was used to search the GenBank database, but no nucleotide or amino acid sequences with significant homology were found.
Analysis of ORF2. Directly following the stop codon of
Lmp1, an open reading frame of 2,886 bp (Lmp2) was identified in the same reading frame as Lmp1. ORF2 thus encoded a putative polypeptide of 110 kDa with a pI of 10.08. Since no Shine-Dalgarno sequence was positioned upstream the putative start methionine, this open reading frame was probably not translated.
DISCUSSION
In this study, an M. hominis surface protein antigen was identified by a MAb, and the corresponding gene was cloned and sequenced. The sequence showed that the 135-kDa protein had a pI of 10 and that it contained multiple tandem repeats of 471 bp. Only a few deviations from the consensus repeat was identified in the lmp1-lmp2 region. This seems exceptional and must be due to either a strong selective evolutionary pressure on the amino acid sequence or the fact that the duplication of the repeats is new on an evolutionary scale, not leaving time to accumulate base pair changes.
The epitope recognized by MAb 552 was present in all of the 26 M. hominis strains tested. In all but four strains, the epitope was located on a 93-kDa antigen (16, 34) . Compared with other surface-exposed antigens analyzed in M. hominis (34, 36) , this uniformity is exceptional. In M. hominis PG21, the MAb 552-defined epitope is encoded by the repetitious part of Lmp1. When hybridizing a DNA probe containing the repeat sequence to the same 26 M. hominis strains, we found a pattern at Penn State Univ on April 14, 2008 iai.asm.org much more complex than the immunoblotting pattern. The pronounced RFLP (14) indicated that genes coding for the protein bearing the MAb 552 epitope vary considerably. Whether this variation involves repetitious elements corresponding to those found in M. hominis PG21 is under investigation. The lmp1-lmp2 region has previously been localized on the physical map of M. hominis PG21 (33) . Work in progress in our laboratory has shown that a second region of approximately 4 kb located more than 121 kb upstream of lmp1 has significant homology to the repeated sequences in the lmp1-lmp2 region. The Lmp1 extracted by Triton X-114 was found in the aqueous phase as well as in the Triton X-114 phase, implying a significant hydrophilicity. Lmp1 is therefore not likely to be an integral part of the mycoplasma membrane, as also indicated by the hydropathy analysis. Washburn et al. (49) have identified a MAb directed against M. arthritidis with MI activity that binds to a protein of the same hydrophilic characteristics. They proposed that the hydrophilic protein may be part of a twocomponent complex consisting of a hydrophobic protein integrated in the membrane and a loosely bound hydrophilic protein exposed on the surface. Our results indicate a similar structure because the two components were incompletely separated during the Triton X-114 extraction, leaving unbound hydrophilic Lmp1 in the aqueous phase and some bound Lmp1 in the Triton X-114 phase.
Feldmann et al. (20) showed that a MAb directed against a 50-kDa surface protein of M. hominis-induced MI and GI. However, they demonstrated that these observations were caused entirely by MAb-induced agglutination of the mycoplasma cells without affecting cell multiplication. Similarly, we found that MAb 552 conferred GI in broth culture as well as MI and agglutination of M. hominis PG21 cells. However, in contrast to Feldmann et al., we found, by the DNA fluorometric assay, that MAb 552 decreased the multiplication rate. The agglutination caused by MAb 552 may be the only factor giving rise to reduced metabolic activities as well as reduced cell multiplication. However, a specific influence by MAb 552 on Lmp1 contributing in part to the decreased viability cannot be excluded.
The restriction map of the lmp1 region indicated a stringent repetitious organization of the lmp1 gene which was confirmed by sequence analysis. The repetitive C-terminal part of the gene constituted more than 80% of the coding region. Even though a number of bacterial surface antigens with repetitive elements have been identified, this is unique among surface antigens (1, 3, 22, 45, 52) .
In mycoplasmas, one of the most thoroughly studied genes with repetitious elements is the vlp gene system of M. hyorhinis. The products of the vlp genes are lipoproteins that show multiple size variations seen as distinctive ladders in immunoblotting. The lipoprotein has been implicated in modulation of host cells with which the mycoplasma interacts (40) . A specific mouse sarcoma cell line with a low tendency to establish invasive tumors greatly increases the invasiveness when infected with M. hyorhinis. The invasiveness can, in turn, be reduced to the background level by treating the cultures with MAb against Vlp. The vlp genes have structural features in common and consist of three regions. Region I contains a typical prokaryotic prolipoprotein signal peptidase recognition sequence. Region II is variable among the Vlps. Region III contains small tandem repeated sequences of 36 or 39 bp. These elements contribute by a precise insertion or deletion to the size variation seen in the surface-exposed lipoprotein (52) . The tandem repeated elements found in lmp1 of M. hominis are considerably longer, 471 bp, than those of M. hyorhinis. Lack of correlation of the size of the repeated elements and the size of the spacing in the ladder pattern seen in M. hominis PG21 and the detection of a single band in Northern blotting (Fig. 7) indicated that the ladder in M. hominis probably did not originate from a mechanism leading to insertions or deletions of repeats in the lmp1 gene as seen in vlp genes. It seems more feasible that the ladder pattern is caused by enzymatic degradation during antigen preparation rather than by recombinational events.
The Lmp1 protein of M. hominis has a N-terminal region homologous to region I of M. hominis, with a typical prokaryotic signal peptide sequence containing a cleavage site for signal peptidase I. The signal peptide contained no Cys residue and thus no acylation site for covalent link to lipid in the membrane. Analogous to region II of Vlp, Lmp1 has a central region without repetitious elements. The overall composition of Lmp1 predicts a hydrophilic protein like the proteineous part of the Vlp lipoprotein. Lmp1 and Vlp have some structural features in common, but the available data do not form a basis of far-reaching conclusions about common functional aspects.
The pI of Lmp1 is very basic. Basic surface proteins of importance for pathogenicity are the P.II, or opacity (Opa), protein of Neisseria gonorrhoeae (21, 46) and the M protein of Streptococcus pyogenes (27) . The Opa protein of N. gonorrhoeae is a surface protein that alters colony opacity. It affects clumping of gonococci and the ability to colonize different host tissues. A single strain can express up to seven different Opa proteins at any time. The opa genes switch their expression states by changing the number of direct pentameric repeated elements encoding the signal peptide of the Opa protein. The M protein of group A streptococci is a primary virulence factor that enables the streptococci to resist phagocytosis by preventing opsonization by complement (27) . The resistance to opsonization is due, in part, to the ability of the M protein to bind fibrinogen (21) . Like Lmp1 the gene encoding the M protein contains repeated elements (27) . The overall amino acid composition of the M protein gives rise to a very basic pI, resulting in a net positively charged molecule as we found for the Lmp1 There is no evidence that the antibodies that confer MI, GI, or agglutination in vitro mediates resistance to mycoplasma disease in vivo (50) . In a study by Cassell et al. (12) , 12 surface proteins of M. hominis were identified by immunoblotting using acute-phase sera from patients with culturally proven infection of the amniotic fluid. Of these, one antigen of 93 kDa was similar in size to Lmp1 found in the majority of the 26 M. hominis strains that we analyzed previously (34) . Identity between Lmp1 and the 93-kDa immunogen remains to be confirmed. A host antibody response to Lmp1 in vivo might, however, play a role in the human immune response.
The identification of immunogenic surface proteins is a first step toward an understanding of the microbe-to-host interactions. The molecular mechanisms underlying the ability of mycoplasma species to vary their surface antigens are not yet clear, and variability has not in any case been definitively linked to immune evasion. The identification the lmp1 gene system may contribute new aspects to this field.
